1. Home
  2. OCUL vs AHCO Comparison

OCUL vs AHCO Comparison

Compare OCUL & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • AHCO
  • Stock Information
  • Founded
  • OCUL 2006
  • AHCO 2012
  • Country
  • OCUL United States
  • AHCO United States
  • Employees
  • OCUL N/A
  • AHCO N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • AHCO Medical/Nursing Services
  • Sector
  • OCUL Health Care
  • AHCO Health Care
  • Exchange
  • OCUL Nasdaq
  • AHCO Nasdaq
  • Market Cap
  • OCUL 1.4B
  • AHCO 1.3B
  • IPO Year
  • OCUL 2014
  • AHCO N/A
  • Fundamental
  • Price
  • OCUL $11.03
  • AHCO $9.29
  • Analyst Decision
  • OCUL Strong Buy
  • AHCO Strong Buy
  • Analyst Count
  • OCUL 7
  • AHCO 5
  • Target Price
  • OCUL $17.33
  • AHCO $13.40
  • AVG Volume (30 Days)
  • OCUL 2.4M
  • AHCO 1.6M
  • Earning Date
  • OCUL 08-06-2025
  • AHCO 08-05-2025
  • Dividend Yield
  • OCUL N/A
  • AHCO N/A
  • EPS Growth
  • OCUL N/A
  • AHCO N/A
  • EPS
  • OCUL N/A
  • AHCO 0.58
  • Revenue
  • OCUL $59,647,000.00
  • AHCO $3,246,360,000.00
  • Revenue This Year
  • OCUL N/A
  • AHCO $1.72
  • Revenue Next Year
  • OCUL $20.05
  • AHCO $4.52
  • P/E Ratio
  • OCUL N/A
  • AHCO $15.95
  • Revenue Growth
  • OCUL N/A
  • AHCO N/A
  • 52 Week Low
  • OCUL $5.79
  • AHCO $7.11
  • 52 Week High
  • OCUL $11.78
  • AHCO $11.90
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 76.75
  • AHCO 53.23
  • Support Level
  • OCUL $9.36
  • AHCO $9.11
  • Resistance Level
  • OCUL $9.75
  • AHCO $9.63
  • Average True Range (ATR)
  • OCUL 0.54
  • AHCO 0.39
  • MACD
  • OCUL 0.18
  • AHCO 0.02
  • Stochastic Oscillator
  • OCUL 91.46
  • AHCO 74.84

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: